HOME     CONTACT     BACK

 
 
 
THE PHARMA REVIEW OCTOBER 2005

Opportunities and Challenges for the Pharma,Bulk Drug &
Biotech Industries: Beyond 2005

P.P. Sheth

Abstract: India being democratic and a knowledge based country offers their Industrialists & trade houses a better environment to boost their pharma manufacturing activities & export their quality products worldwide at competitive rates and this is the only reason why Indian Pharma Companies are shining & established an identity in the Global Market. Today many Indians have returned from advanced countries and establishing Giant Corporate Sectors with the support of the Govt. to make India a world power. It is a matter of pride that all 28 states & 6 union territories are contributing to this in one way or the other.

The day is not far that India will break the international barriers as a leading manufacturer & exporter of low cost bulk drugs, new molecules, pharma & biotech products.

It has emerged that the domestic drugs and pharmaceuticals industry needs reorientation in order to meet the challenges & harness opportunities arising out of the liberalization of the economy and the impending advent of the product patent regime.

India is a gateway for doing business with advanced countries and offers golden opportunity for advance countries to set-up units for bulk drugs / pharma / biotech products manufacturing & marketing operations.

 
Go to Content Index Page

PHARMA REVIEW - ARTICLES ARCHIVE ( COMPLETE LIST)

The above content is an abstract only. For the full Article please contact:
KONGPOSH Publications Pvt. Ltd.
ICS House, C-19, Commercial Complex, SDA, Opp. IIT Gate, New Delhi, India -110016
Tel.: 26855839, 20057149, Fax: 91-11-26855876
Email: info@kppub.com / fpc@vsnl.com, Website: http://www.kppub.com

 
 
 

 Copyright © 2008. KONGPOSH PUBLICATIONS Pvt. Ltd.